NASDAQ:ESPR - Esperion Therapeutics, Inc.
$43.34
 $0.24
+0.56%
4:00PM EDT
2019-07-22
Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). With a targeted mechanism of action, bempedoic acid, the Company's lead product candidate, is an orally available, once-daily adenosine triphosphate (ATP)-citrate lyase (ACL) inhibitor that reduces cholesterol biosynthesis and lowers elevated levels of LDL-C by up-regulating the LDL receptor, but with reduced potential for muscle-related side effects. In addition to bempedoic acid as monotherapy, the Company is also developing bempedoic acid in a fixed dose combination with ezetimibe, an approved, non-statin, oral, LDL-C lowering therapy. As of December 31, 2016, the Company was engaged in conducting its global Phase III clinical development program for bempedoic acid. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ESPR     avg for
industry  
  avg for
sector  
42 stocks weight:  52. 42   217. 37   399. 45  
42 stocks rank:  2. 36 K 1. 27 K 716. 99  
# analyst opinions:  12. 00   13. 21   13. 71  
mean recommendation:  1. 90   2. 10   2. 04  

quick ratio:  3. 81   5. 49   1. 88  
current ratio:  3. 92   5. 87   2. 36  

target price low:  50. 00   83. 44   114. 90  
target price avg:  88. 75   106. 20   137. 90  
target price high:  48. 70   132. 30   158. 97  
1-yr high:  59. 11   111. 86   142. 57  
last close:  43. 10   86. 79   125. 44  
50-day avg:  48. 72   86. 68   122. 63  
200-day avg:  46. 63   89. 22   121. 38  
1-yr low:  36. 99   69. 78   100. 51  
volume:  388. 44 K 2. 62 M 3. 43 M
50-day avg volume:  452. 48 K 3. 20 M 4. 16 M
200-day avg volume:  615. 49 K 2. 99 M 4. 75 M

1-day return:  -2. 47 % -1. 30 % -0. 99 %
this week return:  -5. 30 % 0. 45 % -0. 20 %
12-wk return:  -3. 25 % 0. 94 % 4. 84 %
52-wk return:  1. 03 % -1. 30 % 10. 55 %

enterprise value (EV):  932. 59 M 45. 10 B 122. 38 B
market cap:  1. 16 B 38. 96 B 108. 40 B
EBITDA:  -70. 49 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -13. 23   5. 38   11. 93  
enterprise/revenue (EV/R):  6. 41   57. 92   10. 21  
total revenue:  145. 42 M 9. 91 B 39. 98 B
total debt:  976. 00 K 10. 90 B 17. 48 B
debt/equity:  0. 56   57. 18   120. 05  
net income (common):  -68. 30 M 2. 07 B 4. 05 B

shares outstanding:  26. 75 M 538. 09 M 1. 24 B
shares:  20. 66 M 548. 00 M 1. 22 B
shares short:  5. 26 M 10. 98 M 11. 87 M
shares short prior month:  5. 39 M 9. 32 M 12. 05 M
short ratio:  11. 78   5. 60   3. 34  
short % of float:  25. 74 % 6. 48 % 2. 64 %
total cash/share:  8. 49   10. 98   9. 19  
total cash:  228. 53 M 5. 93 B 6. 10 B
free cash flow:  8. 25 M 2. 92 B 4. 55 B
operating cash flow:  -13. 73 M 3. 80 B 5. 78 B

book value:  6. 50   13. 35   27. 45  
price/book:  6. 63   4. 60   8. 78  
operating margins:  -48. 66 % -308. 40 % -28. 55 %
EBITDA margins:  -48. 47 % 13. 17 % 23. 38 %
profit margins:  -46. 97 % 10. 44 % 14. 18 %
gross margins:  96. 31 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -2. 55   2. 10   4. 23  
forward EPS:  -3. 05   3. 45   7. 10  
P/E:  -16. 88   1. 90   32. 10  
forward P/E:  -14. 13   6. 46   15. 47  
PE/G:  3. 88   0. 70   -0. 54  
growth:  -4. 35 % 265. 63 % 79. 11 %
earnings high:  -1. 66   0. 89   1. 68  
earnings avg:  -1. 87   0. 70   1. 57  
earnings low:  -2. 04   0. 46   1. 46  
revenue high:  1. 53 M 2. 57 B 11. 07 B
revenue avg:  990. 00 K 2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -18. 40 % -2. 34 % 5. 28 %
return on equity:  -35. 10 % -90. 08 % 133. 53 %
revenue/share:  5. 42   12. 72   60. 04  

beta (1yr vs S&P500):  1. 47   1. 27   0. 91  
sharpe (1yr):  0. 28   0. 16   0. 77  

held % insiders:  5. 03 % 6. 06 % 3. 29 %
held % institutions:  108. 59 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : ESPR
.    145.313 =       145.313 :: --> INITIAL WEIGHT <--
.    - 2.553 =        142.76 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.424 =       346.102 :: P/E factor
.    x 0.896 =       309.936 :: PE/G factor
.    x 1.711 =       530.455 :: beta factor
.    x 0.739 =       391.826 :: sharpe factor
.    x 2.668 =      1045.337 :: current ratio factor
.    x 1.165 =      1217.381 :: quick ratio factor
.    x 1.042 =        1268.0 :: short ratio factor
.    x 1.111 =      1408.385 :: EV/R factor
.    x 1.079 =      1519.779 :: price-to-book factor
.    x 5.812 =      8832.907 :: debt-to-revenue factor
.    x 1.005 =        8875.9 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     18823.946 :: sector+industry 1-year gains factor
.    x 1.009 =      19001.42 :: industry 12-weeks return factor
.    x 1.308 =      24851.74 :: industry 2-weeks return factor
.      x 1.0 =     24847.857 :: company one-year gains+dividend factor
.    x 2.057 =     51111.912 :: company 13 weeks' performance factor
.    x 1.045 =     53401.754 :: 50-day avg > 200-day avg
.    x 0.983 =     52507.193 :: "drift" penalty 2 days ago
.    x 0.985 =     51730.097 :: "drift" penalty 5 days ago
.    / 1.943 =     26629.082 :: overall "drift" factor
.    x 0.923 =     24576.546 :: largest single-day jump factor
.        x 1 =     24576.546 :: volatility factor
.        x 1 =     24576.546 :: 42-day volatility factor
.    x 1.553 =     38167.881 :: notable returns + performance factor
.     x 3.45 =     131693.48 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.701 =     92343.609 :: forward EPS factor
.    x 0.891 =      82317.16 :: forward P/E factor
.    x 1.185 =     97522.168 :: industry recommendation factor
.    x 2.455 =    239388.711 :: company recommendation factor
.    x 1.003 =    240050.713 :: factor historical industry gain for week 29
.   x 10.714 =   2571853.493 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        40.046 :: reduced for readability
.   + 11.036 =        51.083 :: add/subtract for investor sentiment
.    + 1.341 =        52.424 :: earnings report in 10 days
.                               --> FINAL WEIGHT <--
.                     52.424 :: FINAL WEIGHT for NASDAQ:ESPR


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org